Abstract
Abstract
Background
Examining past trends and predicting the future helps policymakers to design effective interventions to deal with myocardial infarction (MI) with a clear understanding of the current and future situation. The aim of this study was to estimate the death rate due to MI in Iran by artificial neural network (ANN).
Methods
In this ecological study, the prevalence of diabetes, hypercholesterolemia over 200, hypertension, overweight and obesity were estimated for the years 2017–2025. ANN and Linear regression model were used. Also, Specialists were also asked to predict the death rate due to MI by considering the conditions of 3 conditions (optimistic, pessimistic, and probable), and the predicted process was compared with the modeling process.
Results
Death rate due to MI in Iran is expected to decrease on average, while there will be a significant decrease in the prevalence of hypercholesterolemia 1.031 (− 24.81, 26.88). Also, the trend of diabetes 10.48 (111.45, − 132.42), blood pressure − 110.48 (− 174.04, − 46.91) and obesity and overweight − 35.84 (− 18.66, − 5.02) are slowly increasing. MI death rate in Iran is higher in men but is decreasing on average. Experts' forecasts are different and have predicted a completely upward trend.
Conclusion
The trend predicted by the modeling shows that the death rate due to MI will decrease in the future with a low slope. Improving the infrastructure for providing preventive services to reduce the risk factors for cardiovascular disease in the community is one of the priority measures in the current situation.
Funder
Tabriz University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference46 articles.
1. Jagannathan R, Patel SA, Ali MK, et al. Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr DiabRep. 2019;19(7):1–12.
2. Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–10.
3. Mendis S. Global progress in prevention of cardiovascular disease. Cardiovasc Diagn Therapy. 2017;7(Suppl 1):S32.
4. Jamison DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries. 2006
5. Organization WH. Global status report on noncommunicable diseases 2014: World Health Organization; 2014.